✦ LIBER ✦

Vitreous fluid levels of β-amyloid(1–42)and tau in patients with retinal diseases

✍ Scribed by Shinji Yoneda; Hideaki Hara; Akira Hirata; Mikiko Fukushima; Yasuya Inomata; Hidenobu Tanihara

Publisher: Springer
Year: 2005
Tongue: English
Weight: 123 KB
Volume: 49
Category: Article
ISSN: 0021-5155
DOI: 10.1007/s10384-004-0156-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tau protein and beta-amyloid1-42CSF leve

Tau protein and beta-amyloid1-42CSF levels in different phenotypes of Parkinson’s disease

✍ Hana Přikrylová Vranová; Jan Mareš; Petr Hluštík; Martin Nevrlý; David Stejskal; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 289 KB

Reduction of β-amyloid peptide42 in the

Reduction of β-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease

✍ R. Motter; C. Vigo-Pelfrey; D. Kholodenko; R. Barbour; K. Johnson-Wood; D. Galas 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 545 KB

Inverse association of cortisol serum le

Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Aβ 1–42 ratios in CSF in patients with mild Alzheimer’s disease dementia

✍ Christoph Laske; Elke Stransky; Andreas Fritsche; Gerhard W. Eschweiler; Thomas 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 229 KB

Longitudinal study of cerebrospinal flui

Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in Japan

✍ M. Kanai; E. Matsubara; K. Isoe; K. Urakami; K. Nakashima; H. Arai; H. Sasaki; K 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 919 KB

To clarify the alterations of tau, amyloid beta protein (A beta) 1-40 and A beta1-42(43) in the cerebrospinal fluid (CSF) that accompany normal aging and the progression of Alzheimer's disease (AD), CSF samples of 93 AD patients, 32 longitudinal subjects among these 93 AD patients, 33 patients with

CSF levels of tau, β-amyloid1–42and GAP-

CSF levels of tau, β-amyloid1–42and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

✍ M. Sjögren; L. Minthon; P. Davidsson; A. -K. Granérus; A. Clarberg; H. Vandersti 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 155 KB

Immunoreactivities of amyloid β peptide(

Immunoreactivities of amyloid β peptide(1–42)and total τ protein in lumbar cerebrospinal fluid of patients with normal pressure hydrocephalus

✍ H. Lins; I. Wichart; C. Bancher; C.-W. Wallesch; K. A. Jellinger; N. Rösler 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 196 KB